このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Sintx Technologies 配当金

配当金基準チェック /06

Sintx Technologies配当金を支払った記録がありません。

主要情報

n/a

配当利回り

n/a

配当性向

業界平均利回り	1.7%
次回配当支払日	n/a
配当落ち日	n/a
一株当たり配当金	n/a
一株当たり利益	-US$11.51
配当利回り予想	n/a

最近の配当金アップデート

更新なし

Recent updates

It's Unlikely That The CEO Of Sintx Technologies, Inc. (NASDAQ:SINT) Will See A Huge Pay Rise This Year

Nov 29

Most Shareholders Will Probably Find That The Compensation For Sintx Technologies, Inc.'s (NASDAQ:SINT) CEO Is Reasonable

Dec 09

SINTX Technologies jumps 25%, gets order for aerospace components

Oct 11

SINTX Technologies stock gains 8% premarket on $1.1M grant awarded by US Dept of Energy

Sep 27

SINTX Technologies acquires Technology Assessment and Transfer

Jul 06

SINTX Technologies joins Russell Microcap Index

Jun 09

決済の安定と成長

配当データの取得

安定した配当: SINTの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。

増加する配当: SINTの配当金が増加しているかどうかを判断するにはデータが不十分です。

配当利回り対市場

Sintx Technologies 配当利回り対市場

SINT 配当利回りは市場と比べてどうか？
セグメント	配当利回り
会社 (SINT)	n/a
市場下位25% (US)	1.4%
市場トップ25% (US)	4.3%
業界平均 (Medical Equipment)	1.7%
アナリスト予想 (SINT) (最長3年)	n/a

注目すべき配当: SINTは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。

高配当: SINTは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。

株主への利益配当

収益カバレッジ: SINTの配当性向を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。

株主配当金

キャッシュフローカバレッジ: SINTが配当金を報告していないため、配当金の持続可能性を計算できません。

Sintx Technologies 配当金

配当金 基準チェック /06

主要情報

最近の配当金アップデート

Recent updates

Sintx Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $3.114779 million.

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Sintx Technologies, Inc. Announces Appointment of Eric K. Olson as Chief Executive Officer

Sintx Technologies, Inc. has filed a Follow-on Equity Offering in the amount of $3.115475 million.

Consensus EPS estimates fall by 594%

Sintx Technologies Regains Compliance with Nasdaq Bid Price Requirement

Consensus revenue estimates decrease by 12%

Sintx Technologies Declares 1-for-200 Reverse Stock Split Effective May 28, 2024 to Bring it into Compliance with the Minimum Bid Price Requirements for Maintaining the Listing on the Nasdaq Capital Market

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Sintx Technologies Receives New Notification Letter from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement for Continued Listing on The Nasdaq Capital Market

Sintx Technologies, Inc. has filed a Follow-on Equity Offering.

Full year 2023 earnings: EPS misses analyst expectations

Sintx Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $1.030519 million.

Consensus revenue estimates increase by 17%

Sintx Technologies, Inc. Provides Estimated Revenue for the Fourth Quarter and Full Year Ended December 31, 2023

It's Unlikely That The CEO Of Sintx Technologies, Inc. (NASDAQ:SINT) Will See A Huge Pay Rise This Year

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Sintx Technologies, Inc., Annual General Meeting, Dec 05, 2023

SINTX Technologies Receives a Notice from Nasdaq Listing Qualifications Department of the Nasdaq Stock Market

Sintx Technologies, Inc. Receives Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

New major risk - Revenue and earnings growth

No longer forecast to breakeven

Second quarter 2023 earnings released: US$0.61 loss per share (vs US$10.16 loss in 2Q 2022)

Consensus EPS estimates fall by 16%

Consensus EPS estimates upgraded to US$2.53 loss

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased by 78% to US$23.00

Price target increased by 80% to US$200

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target increased by 70% to US$200

Sintx Technologies, Inc. has completed a Composite Units Offering in the amount of $12.04 million.

Sintx Technologies, Inc. has completed a Composite Units Offering in the amount of $12.04 million.

Sintx Technologies, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2022

Consensus forecasts updated

Most Shareholders Will Probably Find That The Compensation For Sintx Technologies, Inc.'s (NASDAQ:SINT) CEO Is Reasonable

Sintx Technologies Receives Notice from the Listing Qualifications Staff of Nasdaq

Consensus revenue estimates increase by 32%

Insufficient new directors

Sintx Technologies, Inc., Annual General Meeting, Dec 15, 2022

Price target increased to US$2.50

Sintx Technologies, Inc. has completed a Composite Units Offering in the amount of $4.7 million.

SINTX Technologies jumps 25%, gets order for aerospace components

Sintx Technologies, Inc. Announces New Antibacterial Biomedical Patents and Expansion of Intellectual Property Portfolio

National Institutes of Health Announces Grant to Sintx Technologies for Development of 3D Printed Antimicrobial Trauma Device

SINTX Technologies stock gains 8% premarket on $1.1M grant awarded by US Dept of Energy

Oxford Performance Materials and SINTX Technologies Collaboration Yields Major Breakthrough in Orthopedic & Dental Coatings

No longer forecast to breakeven

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Sintx Technologies, Inc. (NasdaqCM:SINT) acquired Technology Assessment And Transfer, Inc. for 0.76 million.

SINTX Technologies acquires Technology Assessment and Transfer

Consensus forecasts updated

Consensus forecasts updated

Price target decreased to US$2.13

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Insufficient new directors

Insufficient new directors

Full year 2021 earnings: EPS and revenues miss analyst expectations

No longer forecast to breakeven

Insufficient new directors

SINTX Technologies, Inc. Announces New Results on the Development of Manufacturing Technologies to Produce Fabrics Impregnated with SINTX Silicon Nitride, and the Antipathogenic Testing of These Fabrics

SINTX Technologies Receives A Notice from Nasdaq Listing Qualifications Department of the Nasdaq Stock Market

No longer forecast to breakeven

Price target decreased to US$3.00

Third quarter 2021 earnings released: US$0.095 loss per share (vs US$0.11 loss in 3Q 2020)

Consensus forecasts updated

Consensus revenue estimates fall to US$1.38m

Price target decreased to US$4.13

Consensus forecasts updated

Sintx Technologies, Inc. Announces the Sale of First Silicon Nitride Antipathogenic Powder to O2TODAY

SINTX Technologies joins Russell Microcap Index

Consensus revenue estimates fall to US$1.10m

First quarter 2021 earnings released: US$0.11 loss per share (vs US$1.35 loss in 1Q 2020)

SINTX Technologies Announces New Product Brand, FleX SN, For Antipathogenic and Biomedical Applications

SINTX Technologies Files Multiple New U.S. and International Patent Applications

Full year 2020 earnings released: US$1.01 loss per share (vs US$4.82 loss in FY 2019)

配当金基準チェック /06